Literature DB >> 17983967

Mood disorders.

Deborah A Yurgelun-Todd1, Simona Sava, Mary Kathryn Dahlgren.   

Abstract

Despite the prevalence of the mood disorders, the underlying neuropathology is still poorly understood. This article describes abnormalities in brain activation that have been reported in neuroimaging studies of patients with depression and bipolar illness. Functional changes have been identified in regions important for neural networks underlying emotional processing, including frontal, subcortical, and limbic regions. The interpretation of neuroimaging studies in mood disorders is limited by potential confounding factors including medication effects, duration of illness, comorbidity, and gender.

Entities:  

Mesh:

Year:  2007        PMID: 17983967     DOI: 10.1016/j.nic.2007.08.001

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  10 in total

1.  Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.

Authors:  John D Salamone; Andrew M Farrar; Laura Font; Vatsal Patel; Devra E Schlar; Eric J Nunes; Lyndsey E Collins; Thomas N Sager
Journal:  Behav Brain Res       Date:  2009-03-03       Impact factor: 3.332

2.  The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists.

Authors:  Lila T Worden; Mona Shahriari; Andrew M Farrar; Kelly S Sink; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2008-12-02       Impact factor: 4.530

3.  The effects of Brief Behavioral Activation Therapy for Depression on cognitive control in affective contexts: An fMRI investigation.

Authors:  Gabriel S Dichter; Jennifer N Felder; Moria J Smoski
Journal:  J Affect Disord       Date:  2010-04-24       Impact factor: 4.839

4.  Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism.

Authors:  E J Nunes; P A Randall; J L Santerre; A B Given; T N Sager; M Correa; J D Salamone
Journal:  Neuroscience       Date:  2010-06-25       Impact factor: 3.590

5.  The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure.

Authors:  Allison M Mott; Eric J Nunes; Lyndsey E Collins; Russell G Port; Kelly S Sink; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2009-01-09       Impact factor: 4.530

6.  Dopamine, effort, and decision making: theoretical comment on Bardgett et al. (2009).

Authors:  John D Salamone
Journal:  Behav Neurosci       Date:  2009-04       Impact factor: 1.912

7.  A genome-wide association study of amygdala activation in youths with and without bipolar disorder.

Authors:  Xinmin Liu; Nirmala Akula; Martha Skup; Melissa A Brotman; Ellen Leibenluft; Francis J McMahon
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-01       Impact factor: 8.829

8.  Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder.

Authors:  Douglas G Kondo; Tracy L Hellem; Young-Hoon Sung; Namkug Kim; Eun-Kee Jeong; Kristen K Delmastro; Xianfeng Shi; Perry F Renshaw
Journal:  Depress Res Treat       Date:  2010-10-04

9.  Modulating affect, cognition, and behavior - prospects of deep brain stimulation for treatment-resistant psychiatric disorders.

Authors:  Thomas E Schlaepfer; Bettina Bewernick; Sarah Kayser; Diane Lenz
Journal:  Front Integr Neurosci       Date:  2011-06-24

Review 10.  The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.

Authors:  Sang Won Jeon; Yong-Ku Kim
Journal:  J Inflamm Res       Date:  2018-05-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.